In the present study, we found that activation of HSF1 via oncogenic H-RasV12 signaling promoted cholesterol biosynthesis and that the suppression of HSF1 sensitized the anticancer effects of simvastatin in HCC cells. Here, HSF1 is linked to hepatocellular carcinoma.